ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Mesoblast Limited

Mesoblast Limited (MSB)

2.59
0.19
( 7.92% )
Updated: 23:15:05

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.59
Bid
2.59
Ask
2.60
Volume
11,082,705
2.41 Day's Range 2.67
0.255 52 Week Range 3.09
Market Cap
Previous Close
2.40
Open
2.41
Last Trade
311
@
2.59
Last Trade Time
23:15:05
Financial Volume
-
VWAP
-
Average Volume (3m)
6,624,068
Shares Outstanding
736,578,315
Dividend Yield
-
PE Ratio
-21.78
Earnings Per Share (EPS)
-0.12
Revenue
9.25M
Net Profit
-87.96M

About Mesoblast Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Melbourne, Victoria, Aus
Founded
-
Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD2.40. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.255 to AUD 3.09.

Mesoblast currently has 736,578,315 shares outstanding. The market capitalization of Mesoblast is AUD1.77 billion. Mesoblast has a price to earnings ratio (PE ratio) of -21.78.

MSB Latest News

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with hypoplastic left heart syndrome. The Australian...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical company's latest setback in its bid to win U.S. Food...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date August 2, 2023 If Approved, Remestemcel-L will be...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company said the U.S. Food and Drug Administration...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the U.S. Food and Drug Administration seeking approval...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug Administration on clinical and potency assay...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during the current quarter to discuss the pathway to U.S...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide license and collaboration agreement with Novartis AG...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is a biopharma company specializing in cell...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.7943.88888888891.83.091.8204070612.6005543DE
41.0770.39473684211.523.091.5102936142.15619985DE
121.46129.2035398231.133.091.1366240681.81809928DE
261.56151.456310681.033.090.8860366961.44229354DE
522.29763.3333333330.33.090.25571092251.06143556DE
1561.22589.74358974361.3653.090.25539703410.93035176DE
2600.5828.8557213932.015.70.25545179491.93926892DE

MSB - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?
The current share price of Mesoblast is AUD 2.59
How many Mesoblast shares are in issue?
Mesoblast has 736,578,315 shares in issue
What is the market cap of Mesoblast?
The market capitalisation of Mesoblast is AUD 1.77B
What is the 1 year trading range for Mesoblast share price?
Mesoblast has traded in the range of AUD 0.255 to AUD 3.09 during the past year
What is the PE ratio of Mesoblast?
The price to earnings ratio of Mesoblast is -21.78
What is the cash to sales ratio of Mesoblast?
The cash to sales ratio of Mesoblast is 206.35
What is the reporting currency for Mesoblast?
Mesoblast reports financial results in USD
What is the latest annual turnover for Mesoblast?
The latest annual turnover of Mesoblast is USD 9.25M
What is the latest annual profit for Mesoblast?
The latest annual profit of Mesoblast is USD -87.96M
What is the registered address of Mesoblast?
The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000
What is the Mesoblast website address?
The website address for Mesoblast is www.mesoblast.com
Which industry sector does Mesoblast operate in?
Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RFGRetail Food Group Limited
AUD 2.56
(3,455.56%)
131.83k
VENVintage Energy Ltd
AUD 0.006
(100.00%)
10.62M
QEMQEM Limited
AUD 0.055
(61.76%)
2.76M
MOMMoab Minerals Ltd
AUD 0.003
(50.00%)
183.33k
LM1Leeuwin Metals Ltd
AUD 0.145
(45.00%)
883.82k
RADOARadiopharm Theranostics Ltd
AUD 0.005
(-50.00%)
513.36k
C29C29 Metals Limited
AUD 0.049
(-47.31%)
984.16k
SPXOASpenda Ltd
AUD 0.003
(-40.00%)
2M
ATHOAlterity Therapeutics Limited
AUD 0.002
(-33.33%)
1M
GCRGolden Cross Resources Ltd
AUD 0.002
(-33.33%)
3.53M
SITSite Group International Ltd
AUD 0.002
(0.00%)
33.46M
VPRVolt Group Ltd
AUD 0.002
(33.33%)
28.69M
BRNBrainchip Holdings Ltd
AUD 0.295
(19.19%)
27.29M
TMGTrigg Minerals Ltd
AUD 0.042
(1.20%)
25.98M
EELENRG Elements Ltd
AUD 0.001
(0.00%)
21.29M

Discussion

View Full Feed
Konaploinks Konaploinks 6 minutes ago
Jack. I agree whole heartedly. And a few of the fence straddling little liars on here make be sick. They always interject these bogus articles written by pure hacks who honestly should be behind bars for trying to manipulate the market. The investing public needs unbiased reporting that reveals all
IONQ
shoondale shoondale 6 minutes ago
Author Jeffrey F. Williams quoted directly on page 9...Safety of MACS- treated soft surfaces for skin and respiratory exposure.
Author: Jeffrey F. Williams
The active ingredients in the MACS formulation are safe for prolonged skin contact, and do not cause irritation or sensitization.
MGON
WooptdooU WooptdooU 8 minutes ago
Again, if lebby owned shares WITH HIS OWN MONEY, would he have done things differently?...this bod continues on the same GRIFT path...talk is cheap...many here ARE LOSING much based on bad actors...let's see what happens...
LWLG
zerosnoop zerosnoop 8 minutes ago
But wait, according to the “experts”, I thought this was supposed to be just a “simple leak test” ? Wonder why they would need to run the device at 40KV for a “simple leak test?” I guess we can also throw the “going against the laws of mother nature” claim out the window as well (I still laugh at th
QSEP
skitahoe skitahoe 9 minutes ago
I hadn't thought about this for some time. My old broker referred to the next two weeks as when the kids are running the candy store. What he was saying was that at most of the major financial firms all the senior people are on vacation, and the junior personnel often like to play games in their a
NWBO
zerosnoop zerosnoop 9 minutes ago
I notice the paid bashers, tax cheats, fraudsters, grubs, uneducated fools with a low IQ & compulsive liars are getting more desperate with their nonsense. The short squeeze is fast approaching. The PROVEN AOT is going GLOBAL.

NAKED SHORT SELLING gets reported differently & isn't part
QSEP
amelia43 amelia43 9 minutes ago
Foreign investors should not be allowed to buy houses in the U.S.
FNMA
zerosnoop zerosnoop 10 minutes ago
The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.
QSEP
Inspector Clouseau Inspector Clouseau 11 minutes ago
I'm sorry I didn't think about Mountain time.Hope we do well here.GLTU
TNXP
Chartmaster Chartmaster 12 minutes ago
Stochastics buy signal given Friday! A pps is holding at the 50 day at 9's, chart ready for lift off this week!
AXXA
Don Faton Don Faton 13 minutes ago
Let's go OPTI.   Sell me some more cheap shares.   I'll make out fine very soon.  ✅
OPTI
blackhawks blackhawks 14 minutes ago
I wonder if you wonder. Start your search for enlightenment by looking up the difference between climate and weather.
Don Faton Don Faton 14 minutes ago
love these children than come on here and whine constantly.  Boo hoo.  You lost money.  Guess what Einstein. It's the OTC.  Most of these companies and their ceos are garbage.  Don't marry the stock, trade them and get out. 

Keep dumping me more low 12s I'll eat em up   Thank you 
OPTI
MrMike241 MrMike241 15 minutes ago
It is 100% verifiable that VOS 5G is real. I have a VOS 5G and it works great!

My post wasn't about any other product. Strawman fallacies don't matter!

As for iVa, I don't know what is real, and that is obviously a big part of why I rarely post here. Haven't you noticed
SRMX
Don Faton Don Faton 16 minutes ago
Wow your a piece of work. LMFAO.   

Please go and take an English class for me asap.   I need an interpreter to understand the brutal words and sentences you type.   

You don't like Brett. Boo hoo. Here is a tissue and now GTFO and go get a job. 😂😂Ƕ
OPTI
ergo sum ergo sum 16 minutes ago
December 21, 2024 (Saturday)

Shortly after midnight last night, the Senate passed the continuing resolution to fund the government through March 14, 2025. The previous continuing resolution ran out at midnight, but as Bloomberg’s congressional budget reporter Steven Dennis explained,
Papa Grizz Papa Grizz 18 minutes ago
4xer, yes indeed the calm before the LT Gain storm. HOPE n WHALE FOMO will be EPIC. The Day of Reckoning is upon us.
SHIBUSD
pos_stock_hoarder pos_stock_hoarder 19 minutes ago
No arguing this fact!

https://scontent-lga3-1.xx.fbcdn.net/v/t39.30808-6/469466854_122126844902534863_7415687975137199667_n.jpg?stp=dst-jpg_p526x296_tt6&_nc_cat=103&ccb=1-7&_nc_sid=aa7b47&_nc_ohc=2XoJm5AtDuQQ7kNvgERc9gA&_nc_zt=23&_nc_ht=scontent-lga3-1.xx&_nc_gid=ARWKS9ETojc8zQypaT1nM
bar1080 bar1080 20 minutes ago
Looks like few things are beating plain jane S&P 500 index funds so far in 2024. Small caps and even mid caps are doing much worse. I had to look up SPLG
BRK.B
SilkRoad SilkRoad 23 minutes ago
Nice job arachnodude
KBLB
SilkRoad SilkRoad 24 minutes ago
Lame effort.
KBLB

Your Recent History

Delayed Upgrade Clock